Zepp Health Corp ADRZEPP
Price$4.02Intrinsic value$4.307% above price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $258.9M+41.8% YoYTTM through 31 Dec 2025
Net Income -$40.1MTTM through 31 Dec 2025
Free Cash Flow -$26.2MTTM through 31 Dec 2025

Margins

Current
Gross Margin38.3%
EBITDA Margin-9.5%
Operating Margin-11.3%
Net Margin-15.5%

Returns

-15.9%ROE
-7.1%ROA

Balance Sheet Health

Debt / Equity0.90x
Current Ratio1.02x
Net Debt$169.9M
Cash & Equivalents$57M

Quality Metrics

Altman Z-Score0.38
Piotroski F-Score5 / 9
FCF Margin-10.1%

Multi-Year Trend

Revenue
'19'20'21'22'23'24'25
FY2025: $258.9M
Diluted EPS-$0.16TTM
'19'20'21'22'23'24'25
FY2025: $-0.16

Dividend

$0.40Per share, FY20220.00%Yield

Capital Allocation

R&D Spend$45.3M
Capex Intensity0.2%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.